3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one, 97%, 500g

2-Naphthaldehyde, 95.00%, 1g

2,5-Dihydroxyphenyl(diphenyl)phosphine Oxide, 98%, 1g

(S)-1-(Methylsulfonyl)pyrrolidin-3-amine hydrochloride, 97%, 50g

3-Isopropyl-1H-indole, 97%, 250mg

XantPhos Pd G3, ?98.0%, 25g

5-Chloro-2-(trifluoromethyl)benzoic acid, 97.0%, 1g

(E)-N-[(4-Fluorophenyl)methylidene]aniline, 98.0%, 25g

tert-Butyl spiro[indene-1,4'-piperidine]-1'-carboxylate, 95.0%, 1g

2-(2-Methyl-1H-imidazol-1-yl)benzonitrile, 97%, 10g

Leuco crystal violet, min. 98%, pa, 25 g, glass packaging

(2R,3R,4S,5R,6R)-2-((Benzoyloxy)methyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl tribenzoate, 98%, 1g

(1S)-((2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol, 95.0%, 5g